Differential regulation of EHD3 in human and mammalian heart failure

Journal of Molecular and Cellular Cardiology

Volumn 52, Issue 5, 2012, Pages 1183-1190

  Gudmundsson, Hjalti ^d   Curran, Jerry ^a   Kashef, Farshid ^a   Snyder, Jedidiah S ^a,b   Smith, Sakima A ^a   Vargas Pinto, Pedro ^a,c   Bonilla, Ingrid M ^a,c   Weiss, Robert M ^d   Anderson, Mark E ^d   Binkley, Philip ^a,b   Felder, Robert B ^d   Carnes, Cynthia A ^a,c   Band, Hamid ^e   Hund, Thomas J ^a,b   Mohler, Peter J ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Animal models; Cardiac remodeling; EHD proteins; Heart failure; Regulation

Indexed keywords

ANGIOTENSIN II; EPS15 HOMOLOGY DOMAIN CONTAINING PROTEIN 3; MEMBRANE PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SODIUM CALCIUM EXCHANGE PROTEIN; UNCLASSIFIED DRUG;

ADULT ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; FEMALE; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE OVERLOAD; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART PACING; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; MALE; MOUSE; NEWBORN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANGIOTENSIN II; ANIMALS; CARRIER PROTEINS; CASE-CONTROL STUDIES; CELLS, CULTURED; DOGS; GENE EXPRESSION REGULATION; HEART FAILURE; HEART VENTRICLES; HUMANS; MALE; MICE; MICE, INBRED C57BL; MYOCYTES, CARDIAC; NADPH OXIDASE; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SODIUM-CALCIUM EXCHANGER;

ANIMALIA; MAMMALIA; RATTUS;

EID: 84862795710     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2012.02.008     Document Type: Article

References (49)

1. McMurray J.J., Pfeffer M.A. Heart failure. Lancet 2005, 365:1877-1889.
2. Valdivia C.R., Chu W.W., Pu J., Foell J.D., Haworth R.A., Wolff M.R., et al. Increased late sodium current in myocytes from a canine heart failure model and from failing human heart. J Mol Cell Cardiol 2005, 38:475-483.
3. 2+]i in rat ventricular myocytes following myocardial infarction. J Physiol 1999, 517(Pt 1):229-245.
4. 2+ exchanger remodeling in pressure overload cardiac hypertrophy. J Biol Chem 2001, 276:17706-17711.
5. 2+ exchanger in end-stage human heart failure. Circ Res 1994, 75:443-453.
6. Caplan S., Naslavsky N., Hartnell L.M., Lodge R., Polishchuk R.S., Donaldson J.G., et al. A tubular EHD1-containing compartment involved in the recycling of major histocompatibility complex class I molecules to the plasma membrane. EMBO J 2002, 21:2557-2567.
7. George M., Ying G., Rainey M.A., Solomon A., Parikh P.T., Gao Q., et al. Shared as well as distinct roles of EHD proteins revealed by biochemical and functional comparisons in mammalian cells and C. elegans. BMC Cell Biol 2007, 8:3.
8. Grant B., Zhang Y., Paupard M.C., Lin S.X., Hall D.H., Hirsh D. Evidence that RME-1, a conserved C. elegans EH-domain protein, functions in endocytic recycling. Nat Cell Biol 2001, 3:573-579.
9. Grant B.D., Caplan S. Mechanisms of EHD/RME-1 protein function in endocytic transport. Traffic 2008, 9:2043-2052.
10. Gudmundsson H., Hund T.J., Wright P.J., Kline C.F., Snyder J.S., Qian L., et al. EH domain proteins regulate cardiac membrane protein targeting. Circ Res 2010, 107:84-95.
11. Cunha S.R., Mohler P.J. Obscurin targets ankyrin-B and protein phosphatase 2A to the cardiac M-line. J Biol Chem 2008, 283:31968-31980.
12. Mohler P.J., Davis J.Q., Bennett V. Ankyrin-B coordinates the Na/K ATPase, Na/Ca exchanger, and InsP3 receptor in a cardiac T-tubule/SR microdomain. PLoS Biol 2005, 3:e423.
13. Francis J., Weiss R.M., Wei S.G., Johnson A.K., Felder R.B. Progression of heart failure after myocardial infarction in the rat. Am J Physiol Regul Integr Comp Physiol 2001, 281:R1734-R1745.
14. Wei S., Guo A., Chen B., Kutschke W., Xie Y.P., Zimmerman K., et al. T-tubule remodeling during transition from hypertrophy to heart failure. Circ Res 2010, 107:520-531.
15. van Oort R.J., McCauley M.D., Dixit S.S., Pereira L., Yang Y., Respress J.L., et al. Ryanodine receptor phosphorylation by calcium/calmodulin-dependent protein kinase II promotes life-threatening ventricular arrhythmias in mice with heart failure. Circulation 2010, 122:2669-2679.
16. Nishijima Y., Feldman D.S., Bonagura J.D., Ozkanlar Y., Jenkins P.J., Lacombe V.A., et al. Canine nonischemic left ventricular dysfunction: a model of chronic human cardiomyopathy. J Card Fail 2005, 11:638-644.
17. Francis J., Weiss R.M., Johnson A.K., Felder R.B. Central mineralocorticoid receptor blockade decreases plasma TNF-alpha after coronary artery ligation in rats. Am J Physiol Regul Integr Comp Physiol 2003, 284:R328-R335.
18. Tilley D.G., Rockman H.A. Role of beta-adrenergic receptor signaling and desensitization in heart failure: new concepts and prospects for treatment. Expert Rev Cardiovasc Ther 2006, 4:417-432.
19. Xiao C.Y., Chen M., Zsengeller Z., Li H., Kiss L., Kollai M., et al. Poly(ADP-ribose) polymerase promotes cardiac remodeling, contractile failure, and translocation of apoptosis-inducing factor in a murine experimental model of aortic banding and heart failure. J Pharmacol Exp Ther 2005, 312:891-898.
20. Rockman H.A., Ross R.S., Harris A.N., Knowlton K.U., Steinhelper M.E., Field L.J., et al. Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc Natl Acad Sci U S A 1991, 88:8277-8281.
21. Sadoshima J., Izumo S. The cellular and molecular response of cardiac myocytes to mechanical stress. Annu Rev Physiol 1997, 59:551-571.
22. Malhotra R., Sadoshima J., Brosius F.C., Izumo S. Mechanical stretch and angiotensin II differentially upregulate the renin-angiotensin system in cardiac myocytes in vitro. Circ Res 1999, 85:137-146.
23. Hilfiker-Kleiner D.L., U, Drexler H. Molecular mechanisms in heart failure: focus on cardiac hypertrophy, inflammation, angiogenesis, and apoptosis. JACC 2006, 48(Supplement A).
24. Xie L.H., Chen F., Karagueuzian H.S., Weiss J.N. Oxidative-stress-induced afterdepolarizations and calmodulin kinase II signaling. Circ Res 2009, 104:79-86.
25. Li J.M., Gall N.P., Grieve D.J., Chen M., Shah A.M. Activation of NADPH oxidase during progression of cardiac hypertrophy to failure. Hypertension 2002, 40:477-484.
26. Bendall J.K., Cave A.C., Heymes C., Gall N., Shah A.M. Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice. Circulation 2002, 105:293-296.
27. Suzuki H., Frank G.D., Utsunomiya H., Higuchi S., Eguchi S. Current understanding of the mechanism and role of ROS in angiotensin II signal transduction. Curr Pharm Biotechnol 2006, 7:81-86.
28. Pohl U., Smith J.S., Tachibana I., Ueki K., Lee H.K., Ramaswamy S., et al. EHD2, EHD3, and EHD4 encode novel members of a highly conserved family of EH domain-containing proteins. Genomics 2000, 63:255-262.
29. Mintz L., Galperin E., Pasmanik-Chor M., Tulzinsky S., Bromberg Y., Kozak C.A., et al. EHD1-an EH-domain-containing protein with a specific expression pattern. Genomics 1999, 59:66-76.
30. Naslavsky N., Rahajeng J., Sharma M., Jovic M., Caplan S. Interactions between EHD proteins and Rab11-FIP2: a role for EHD3 in early endosomal transport. Mol Biol Cell 2006, 17:163-177.
31. Blume J.J., Halbach A., Behrendt D., Paulsson M., Plomann M. EHD proteins are associated with tubular and vesicular compartments and interact with specific phospholipids. Exp Cell Res 2007, 313:219-231.
32. Daumke O., Lundmark R., Vallis Y., Martens S., Butler P.J., McMahon H.T. Architectural and mechanistic insights into an EHD ATPase involved in membrane remodelling. Nature 2007, 449:923-927.
33. Guilherme A., Soriano N.A., Furcinitti P.S., Czech M.P. Role of EHD1 and EHBP1 in perinuclear sorting and insulin-regulated GLUT4 recycling in 3T3-L1 adipocytes. J Biol Chem 2004, 279:40062-40075.
34. Jovic M., Naslavsky N., Rapaport D., Horowitz M., Caplan S. EHD1 regulates beta1 integrin endosomal transport: effects on focal adhesions, cell spreading and migration. J Cell Sci 2007, 120:802-814.
35. Walseng E., Bakke O., Roche P.A. Major histocompatibility complex class II-peptide complexes internalize using a clathrin- and dynamin-independent endocytosis pathway. J Biol Chem 2008, 283:14717-14727.
36. Sharma M., Naslavsky N., Caplan S. A role for EHD4 in the regulation of early endosomal transport. Traffic 2008, 9:995-1018.
37. Poupon V., Begue B., Gagnon J., Dautry-Varsat A., Cerf-Bensussan N., Benmerah A. Molecular cloning and characterization of MT-ACT48, a novel mitochondrial acyl-CoA thioesterase. J Biol Chem 1999, 274:19188-19194.
38. Hollander J.M., Baseler W.A., Dabkowski E.R. Proteomic remodeling of mitochondria in heart failure. Congest Heart Fail 2011, 17:262-268.
39. Sipido K.R., Volders P.G., Vos M.A., Verdonck F. Altered Na/Ca exchange activity in cardiac hypertrophy and heart failure: a new target for therapy?. Cardiovasc Res 2002, 53:782-805.
40. Sipido K.R., Volders P.G., de Groot S.H., Verdonck F., Van de Werf F., Wellens H.J., et al. Enhanced Ca(2+) release and Na/Ca exchange activity in hypertrophied canine ventricular myocytes: potential link between contractile adaptation and arrhythmogenesis. Circulation 2000, 102:2137-2144.
41. Sipido K.R., Volders P.G., Schoenmakers M., De Groot S.H., Verdonck F., Vos M.A. Role of the Na/Ca exchanger in arrhythmias in compensated hypertrophy. Ann N Y Acad Sci 2002, 976:438-445.
42. 2+ ATPase transport capacity regulates the contractility of normal and hypertrophied feline ventricular myocytes. J Card Fail 2005, 11:380-387.
43. Krijnen P.A., Meischl C., Hack C.E., Meijer C.J., Visser C.A., Roos D., et al. Increased Nox2 expression in human cardiomyocytes after acute myocardial infarction. J Clin Pathol 2003, 56:194-199.
44. Kuroda J., Ago T., Matsushima S., Zhai P., Schneider M.D., Sadoshima J. NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart. Proc Natl Acad Sci U S A 2010, 107:15565-15570.
45. Fukui T., Yoshiyama M., Hanatani A., Omura T., Yoshikawa J., Abe Y. Expression of p22-phox and gp91-phox, essential components of NADPH oxidase, increases after myocardial infarction. Biochem Biophys Res Commun 2001, 281:1200-1206.
46. Hill M.F., Singal P.K. Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats. Am J Pathol 1996, 148:291-300.
47. Nishijima Y., Sridhar A., Bonilla I., Velayutham M., Khan M., Terentyeva R., et al. Tetrahydrobiopterin depletion and NOS2 uncoupling contribute to heart failure-induced alterations in atrial electrophysiology. Cardiovasc Res 2011, 91:71-79.
48. Byrne J.A., Grieve D.J., Bendall J.K., Li J.M., Gove C., Lambeth J.D., et al. Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy. Circ Res 2003, 93:802-805.
49. Lyle A.N., Griendling K.K. Modulation of vascular smooth muscle signaling by reactive oxygen species. Physiology (Bethesda) 2006, 21:269-280.